【レポートの概要(一部)】
1. Report Overview
1.1 World IBD Drugs Market: Overview of Findings
1.2 Why You Should Read This Report
1.3 How That Study Delivers Value
1.4 Main Questions Covered in That Analysis
1.5 Who is the Investigation For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Titles
1.9 About Visiongain
2. Introduction to the Inflammatory Bowel Disease Market
2.1 What is Inflammatory Bowel Disease (IBD)?
2.2 Classification of IBD
2.3 Symptoms and Diagnosis of IBD
2.4 Multifactorial Causes of IBD
2.5 How Common is IBD?
2.6 What Are the Treatment Options for IBD?
2.6.1 Aminosalicylates – The Most Common Therapy
2.6.2 Antibiotics – Will There Be Any Supporting Evidence Soon?
2.6.3 Corticosteroids – Uptake from Uceris?
2.6.4 Immunomodulators – Slow to Act?
2.6.5 Monoclonal Antibodies – Not Cost-effective?
2.7 Treatment Goals for IBD – Treat-to-Target Approach?
2.8 Treatment Algorithm – is Top-Down Approach the Future Direction?
3. The World Inflammatory Bowel Disease Market, 2014-2025
3.1 The Inflammatory Bowel Disease Market in 2013 and 2014
3.2 Forecast 2014-2025: Changes Expected?
3.3 Biologic Therapies Forecast 2014-2025 – The Future of Pharma
3.4 Aminosalicylates Forecast 2014-2025: The Work Horse of IBD Market
3.5 Antibiotics Forecast 2014-2025: Scientific Research Important
3.6 Corticosteroids Forecast 2014-2025: Will Uceris Save the Day?
3.7 Immunomodulators Forecast 2014-2025 – Will It Remain Insignificant?
4. Market Prospects for Leading IBD Drugs, 2014-2025
4.1 Humira (AbbVie) – Will It Stand the Wave of Biosimilars?
4.1.1 Humira: Forecast and Analysis, 2014-2025
4.2 Remicade (Janssen Biotech) – Rise and Fall with Humira?
4.2.1 Remicade: Forecast and Analysis, 2014-2025
4.3 Asacol (Actavis) – Will It Regain Its Revenue?
4.3.1 Asacol: Forecast and Analysis, 2014-2025
4.4 Pentasa (Shire) – When Will a Generic Substitute Arrive?
4.4.1 Pentasa: Forecast and Analysis, 2014-2025
4.5 Lialda (Shire) – Will Improved Compliance Increase Revenue?
4.5.1 Lialda: Forecast and Analysis, 2014-2025
4.6 Tysabri (Perrigo) – How Dependable its Prospects?
4.6.1 Tysabri: Forecast and Analysis, 2014-2025
4.7 Xifaxan (Salix Pharmaceuticals) – Growing Stronger?
4.7.1 Xifaxan: Forecast and Analysis, 2014-2025
4.8 Cimzia (UCB) – How Will it Fare Against Biosimilars?
4.8.1 Cimzia: Forecast and Analysis, 2014-2025
4.9 Entocort (AstraZeneca) – A Slow and Steady Decline?
4.9.1 Entocort: Forecast and Analysis, 2014-2025
4.10 Neoral (Novartis) – Immunosuppressant
4.10.1 Neoral: Forecast and Analysis, 2014-2025
4.11 Medrol (Pfizer Inc.) – Another Leading Steroid
4.11.1 Medrol: Forecast and Analysis, 2014-2025
4.12 Canasa (Actavis) – A Slow Decline?
4.12.1 Canasa/Salofalk: Forecast and Analysis, 2014-2025
4.13 Apriso (Salix Pharmaceuticals) – Challenger to Asacol?
4.13.1 Apriso: Forecast and Analysis, 2014-2025
4.14 Azulfidine (Pfizer) – Established Product
4.14.1 Azulfidine: Forecast and Analysis, 2014-2025
4.15 Entyvio (Takeda Pharmaceuticals) – a Future Star Product?
4.15.1 Entyvio: Forecast and Analysis, 2014-2025
4.16 Simponi (Janssen Biotech) – Another Rising Star for the Market?
4.16.1 Simponi: Forecast and Analysis, 2014-2025
4.17 Uceris (Salix) – Corticosteroid for Maintenance Therapy?
4.17.1 Uceris: Forecast and Analysis, 2014-2025
5. Leading National Markets: Sales Outlooks, 2014-2025
5.1 IBD Drugs – Leading National Markets 2013
5.2 The US IBD Drug Market, 2014-2025 – The World Leader
5.3 The Japanese IBD Drug Market, 2014-2025 – Growing Significantly?
5.4 The EU-5 IBD Drug Market, 2014-2025 – Still Growing Together
5.4.1 The German IBD Drug Market, 2014-2025
5.4.2 The French IBD Drug Market, 2014-2025
5.4.3 The UK IBD Drug Market, 2014-2025
5.4.4 The Spanish IBD Drug Market, 2014-2025
5.4.5 The Italian IBD Drug Market, 2014-2025
5.5 IBD Drug Markets in BRIC Countries – How Fast Will They Grow?
5.5.1 The Brazilian IBD Drug Market, 2014-2025
5.5.2 The Russian IBD Drug Market, 2014-2025
5.5.3 The Indian Drug Market, 2014-2025
5.5.4 The Chinese IBD Drug Market, 2014-2025
6. The R&D Pipeline for Inflammatory Bowel Disease, 2014
6.1 Interleukin (IL) Inhibitors – One of the Main Areas of Innovation
6.1.1 CyCol (Sigmoid Pharma)
6.1.2 PF-04236921 (Pfizer)
6.1.3 QAX 576 (Novartis)
6.1.4 TNF Kinoid (Neovacs)
6.1.5 Vidofludimus (4SC) – Suspended
6.1.6 Stelara (Ustekinumab, CNTO 1275, Janssen Biotech)
6.2 Cell-Adhesion Molecule (CAM) Inhibitors – A Promising Avenue
6.2.1 AJG 511 (Ajinomoto Pharmaceutical Co.)
6.2.2 AJM 300 (Ajinomoto Pharmaceuticals)
6.2.3 MEDI 7183/AMG 181 (AstraZeneca & Amgen)
6.2.4 Etrolizumab (Roche)
6.2.5 PF-00547659 (Pfizer)
6.2.6 Alicaforsen (ISIS 2302, Atlantic Healthcare)
6.2.7 MEDI-2070/AMG 139 (AstraZeneca & Amgen)
6.2.8 Entyvio (Vedolizumab, Takeda)
6.3 TNF Inhibitors – a Specific Target
6.3.1 AVX-470 (Avaxia Biologics)
6.3.2 Ozoralizumab (ALX-0061, Ablynx)
6.4 Stem Cell Therapies – Basis for a Cure?
6.4.1 Ovasave (TxCell)
6.4.2 MultiStem (Athersys and Pfizer)
6.4.3 Prochymal (Remestemcel-L, Osiris Therapeutics)
6.4.4 Cx601 (TiGenix
6.5 JAK Inhibitors – New Target Pathway
6.5.1 JNJ-54781532 (Janssen)
6.5.2 Xeljanz, (Tofacitinib, CP-690550, Pfizer)
6.6 Toll-like Receptor Agonists
6.6.1 BL-7040 (BioLineRX)
6.6.2 Kappaproct (InDex Pharmaceuticals)
6.7 Other Classes of Agent
6.7.1 Trichuris suis ova (CNDO-201, Coronado Biosciences)
6.7.2 GLPG0974 (Galapagos)
6.7.3 RPC1063 (Receptos)
6.7.4 SGX203 (Soligenix)
6.7.5 Mongersen (GED-0301, Celgene)
6.7.6 Tetomilast (OPC-6535, Otsuka)
6.7.7 Laquinimod (Active Biotech)
6.7.8 RHB-104 (RedHill Biopharma)
6.7.9 TRK 170 (Toray Industries)
6.8 Biosimilars Candidates – Promising Copies of Leading Biologics?
6.8.1 Possibility of Adalimumab Biosimilars
6.8.2 Possibility of Infliximab Biosimilars
7. Drivers and Restraints in the Inflammatory Bowel Disease Drug Industry and Market, 2015
7.1 SWOT and STEP Analysis of the IBD Market
7.2 What Factors Will Stimulate the IBD Market?
7.2.1 Increasing Disease Incidence
7.2.2 Better Diagnosis – Early Referrals
7.2.3 Delivery Systems
7.2.4 Biological Drugs
7.2.5 Socioeconomic Costs of IBD
7.3 What Factors Will Restrain the Market?
7.3.1 Lack of Understanding of Disease Aetiology
7.3.2 Compliance
7.3.3 Limits of Biologics
7.3.4 The Possible Development of Alternative Treatments
7.3.5 Surgery – Treatment for Recalcitrant IBD
7.3.6 Health Care Cost Containment
8. Leading Companies in the IBD Market, 2014
8.1 The Largest Companies by Revenue
8.1.1 AbbVie – Current Leader and Continually Expanding
8.1.2 Janssen Biotech – Contender for Future Leader of that Market
8.1.3 Actavis – New Comer in the Top Four
8.1.4 Shire Pharmaceuticals – Products and R&D
9. Research Interviews
9.1 Dr Karine Kleinhaus, Divisional Vice President, North America, Pluristem Therapeutics Inc.
9.1.1 On Pluristem Therapeutics Inc.
9.1.2 On PLX Cells
9.1.3 MoA of PLX Cells and What They are Indicated For
9.1.4 Clinical Trial for IBD Indication
9.1.5 Prospects of PLX Cells as a Treatment Option for IBD
9.1.6 On NIH’s Initiation of the Human Placental Project
9.1.7 Cell Therapy and its Place in Biopharma Development
9.1.8 Bridging Clinical Trial and Clinical Outcome
9.1.9 On Pluristem’s Partnerships
9.2 Dr Qamar ul Arfin, Gastroenterologist, Aga Khan University Hospital, Karachi, Pakistan
9.2.1 On Antibiotics in Treating IBD
9.2.2 On the Emergence of Biologic Therapies
9.2.3 On IBD in the Pakistani Context
9.2.4 On Preventative Measures that Can Be Taken
10. Conclusions of the Study
10.1 IBD Market to Expand from 2014 to 2025
10.2 Aminosalicylates and Other Non-Biologic Treatments
10.3 Biological Treatments
10.4 Improvements Needed in IBD Therapy
10.5 Future IBD Treatments: R&D Efforts Look Promising
10.6 The IBD Sector: Looking to the Future with Confidence
【レポート販売概要】
■ タイトル:世界の炎症性腸疾患(IBD)治療薬市場■ 英文:Inflammatory Bowel Diseases (IBD): World Drug Industry and Market 2015-2025
■ 発行日:2014年11月
■ 調査会社:visiongain
■ 商品コード:VGAIN4120208
■ 調査対象地域:グローバル
- 硫酸ナトリウムの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world sodium sulphate market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true i …
- 個人用アクセサリの世界市場:ジュエリー、時計、バック、筆記具About Personal Accessories Market This report on the global personal accessories market is structured keeping in mind the jewelry, bags, watches, and writing and marking instruments market. The personal accessories market is considered to be a very niche market, which is slowly making its mark on the global forum. India, US, and China are the largest jewelry markets. The bags and watches markets a …
- ヘルスケア及び生命科学産業向け自然言語処理(NLP)の世界市場The advent of Electronic Health Records (EHR) has prioritized the use of innovative technologies. Many healthcare and life sciences business organizations are progressively seeking high end NLP technologies which would provide them better and quick access to the clinical data to derive better results for medical diagnosis. There is an explosive growth of unstructured clinical data, and healthcare …
- CooperVision, Inc.:市場シェア分析CooperVision, Inc. Market Share Analysis Summary GlobalData’s new report, “CooperVision, Inc. Market Share Analysis” provides in-depth information on CooperVision, Inc.’s market position in the different medical equipment markets it operates in. The report provides CooperVision, Inc. market share information in one key market category – Vision Care. The report also provides data and information on …
- ヘルニア(Hernia):世界の治験レビュー(2015年上半期版)Hernia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hernia Global Clinical Trials Review, H1, 2015" provides an overview of Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The re …
- Hologic, Inc.:市場シェア分析Hologic, Inc. Market Share Analysis Summary GlobalData’s new report, “Hologic, Inc. Market Share Analysis” provides in-depth information on Hologic, Inc.’s market position in the different medical equipment markets it operates in. The report provides Hologic, Inc. market share information in three key market categories – Infectious Immunology, Bone Densitometers and Mammography Equipment. The repo …
- バッテリー式電気自動車(BEV)の世界市場:主要企業動向、販売予測、充電ステーションインフラ予測The latest report from business intelligence provider visiongain offers comprehensive analysis of the global Battery Electric Vehicle (BEV) market. Visiongaain assesses that the BEV market will generate revenues of $46.3bn in 2015. Now: "Consumers have largely shunned electric vehicles because of their high price tags and limited driving range, as well as the scarcity of charging stations, though …
- Comprehensive MVNO/MVNE PackageThis package is simply the most comprehensive package available in the market. It includes a real MVNO Business Plan from an actual launch plan. It includes a complete pre-paid MVNO business plan with information to support planning needs while easy to modify to reflect different strategies. It also includes a fully functional MVNO Business Plan Spreadsheet (in Excel) enabling financial forecastin …
- クラウド基盤のモバイル付加価サービス(VAS):セキュリティ課題、市場機会、予測2013-2018(Mobile Value-added Services (VAS) in the Cloud: Security Challenges, Market Opportunities and Forecasts 2013 – 2018)Cloud computing has started to play a crucial role in mobile based value-added service (VAS) offering as end-users appetite for applications is ever-increasing and service providers are increasingly moving towards alternative service platforms and support infrastructure. Mobile VAS in the Cloud includes communications, content, commerce and applications of various types. Leading companies are posi …
- 機能性食品の世界市場分析:製品別(カロテノイド、食物繊維、脂肪酸、鉱物、プレバイオティクス・プロビオティック、ビタミン)、用途別、エンドユーザー別(スポーツ栄養、体重管理、免疫、消化器の健康)、セグメント予測、2014 – 2024The global functional foods market is expected to reach USD 255.10 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population, healthcare costs, consumers ‘consciousness towards their well-being, and changing lifestyle is expected to drive the functional foods market growth over the forecast period. These foods have the ability to combat various diseases p …
- ヒューマンマシンインタフェース(HMI)の世界市場予測(~2022):提供方法別(ハードウェア(基本HMI、高度PCベースHMI、高度パネルベースHMI)、ソフトウェア(オンプレミスHMI、クラウドベースHMI))、構成種類別The human machine interface market (HMI) is expected to be worth USD 5.86 Billion by 2022, growing at a CAGR of 9.0% between 2016 and 2022. The growth of this market is propelled by growing acceptance of industrial automation equipment in the manufacturing sector, evolution of industrial internet of things (IIoT) and increasing demand for smart automation solution, and growing need of efficiency a …
- 世界の産業用無線オートメーション市場動向:Global Industrial Wireless Automation Market 2014-2018TechNavio's analysts forecast the Global Industrial Wireless Automation market to grow at a CAGR of 15.68 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing need for remote monitoring. The Global Industrial Wireless Automation market has also been witnessing growth driven by recent developments in wireless technology. However, the reliabi …
- ハイブリッド複合材料の世界市場2019-2023Global Hybrid Composites Market: About this market Hybrid composites are high-performance materials that are fabricated by mixing two or more types of fibers in resin to combine properties such as compressive strength, impact strength, and tensile strength. Technavio’s hybrid composites market analysis considers sales from both thermoset hybrid composites and thermoplastic hybrid composites. Our a …
- ブラジルの化粧品市場2015-2019Technavios research analyst predicts the cosmetics market in Brazil to grow at a CAGR of 11% during the forecast period. The increase in the number of working women is the primary driver for the growth of this market. The need to look fresh and presentable at the workplace is the key reason for the increase in expenditure on cosmetics by working women. Moreover, women in Brazil are now more inform …
- 調査用機器の世界市場:レベル、レーザー、距離測定機器、経緯儀、スキャナー、GNSS/GPS、小型UAV、測位システム、水中音響機器、海洋観測機器等The survey equipment market is expected to grow at a CAGR of 6.49% from 2014 to 2020. This report includes a financial analysis of the key players in the market, historical market analysis, technology trends, market environment analysis, industry overview which includes supply chain analysis, value chain analysis and demand model for the market. It also includes the key drivers and restraints whic …